EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors

Emilia L Bialek, Roos Buds, Ingrid Dijkgraaf, Pedro E Marques iD

Basic & Clinical Pharmacology & Toxicology · 2026-10 · 139 (4)

DOI: 10.1111/bcpt.70281 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 10.09.2026. Verfasst von Emilia L Bialek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Chemokines, Inflammation, Ticks. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fonds Wetenschappelijk Onderzoek, KU Leuven, Global PhD Partnerships between KU Leuven and Maastricht University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ticks are haematophagous parasites that rely on uninterrupted bloodmeals for survival and need an effective strategy to suppress the host inflammatory response. Leukocyte recruitment is a chemokine‐mediated hallmark of inflammation, which ticks counteract via anti‐chemokine proteins in their saliva named evasins. They are a heterogeneous family of glycoproteins that redundantly bind and inhibit chemokines. We provide a detailed overview of their chemokine‐binding properties, as well as their therapeutic efficacy in models of inflammation in vivo. Moreover, we discuss the potential challenges posed by using evasins in a therapeutic setting and explore how the development of modified evasins might aid this.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChemokinesInflammationTicksAnimalsHumansAnti-Inflammatory Agents

Substanzen

ChemokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Laboratory of Molecular Immunology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Biochemistry (CARIM), Maastricht University, Maastricht, the Netherlands.
  • Department of Radiology and Nuclear Medicine, Maastricht UMC+, Maastricht, the Netherlands.

ORCID-Profile: Pedro E Marques

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • KU Leuven
  • Global PhD Partnerships between KU Leuven and Maastricht University

Zitieren

APA

Bialek, E. L., Buds, R., Dijkgraaf, I., & Marques, P. E. (2026). Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors. Basic & Clinical Pharmacology & Toxicology, 139(4). https://doi.org/10.1111/bcpt.70281

Vancouver

Bialek EL, Buds R, Dijkgraaf I, Marques PE. Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors. Basic & Clinical Pharmacology & Toxicology. 2026;139(4). doi:10.1111/bcpt.70281

BibTeX
@article{Bialek2026,
  author = {Bialek, Emilia L and Buds, Roos and Dijkgraaf, Ingrid and Marques, Pedro E},
  title = {Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {4},
  doi = {10.1111/bcpt.70281}
}
Kostenlos starten →